Enhanced removal of cholesterol from macrophage foam cells to serum from type IV hypertriglyceridemic subjects

Atherosclerosis

Volumn 198, Issue 1, 2008, Pages 49-56

  Attia, Nesrine ^a   Ramaharo, Angela ^a   Paul, Jean Louis ^a,b   Cambillau, Michèle ^b   Beaune, Philippe ^b   Grynberg, Alain ^a   Simon, Alain ^c   Fournier, Natalie ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c HÔPITAL BROUSSAIS   (France)

Author keywords

ATP binding cassette transporter A1; cAMP pretreated J774 mouse macrophages; Cholesterol efflux; Cholesteryl ester; Foam cells; Hypertriglyceridemia; Pre HDL

Indexed keywords

ABC TRANSPORTER A1; ACETYL LOW DENSITY LIPOPROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; CYCLIC AMP; PRE BETA HIGH DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR RISK; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; FOAM CELL; HUMAN; HYPERTRIGLYCERIDEMIA; HYPERTRIGLYCERIDEMIA TYPE 2B; HYPERTRIGLYCERIDEMIA TYPE IV; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK FACTOR; SERUM; UPREGULATION;

ADULT; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FOAM CELLS; HUMANS; HYPERLIPOPROTEINEMIA TYPE IV; LIPOPROTEINS, LDL; MALE; MICE; MIDDLE AGED; SCAVENGER RECEPTORS, CLASS B; TRIGLYCERIDES; TRITIUM;

EID: 40949111073     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.09.023     Document Type: Article

References (40)

1. Barter P.J., and Rye K.A. High density lipoproteins and coronary heart disease. Atherosclerosis 121 (1996) 1-12
2. von Eckardstein A., Nofer J.R., and Assmann G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21 (2001) 13-27
3. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., and Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 40 (1999) 781-796
4. Yancey P.G., Bortnick A.E., Kellner-Weibel G., de la Llera-Moya M., Phillips M.C., and Rothblat G.H. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 23 (2003) 712-719
5. van Dam M.J., de Groot E., Clee S.M., et al. Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet 359 (2002) 37-42
6. Favari E., Lee M., Calabresi L., et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 279 (2004) 9930-9936
7. Fournier N., Paul J.L., Atger V., et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum. Arterioscler Thromb Vasc Biol 17 (1997) 2685-2691
8. Wang N., Lan D., Chen W., Matsuura F., and Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc Natl Acad Sci USA 101 (2004) 9774-9779
9. Gelissen I.C., Harris M., Rye K.A., et al. ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I. Arterioscler Thromb Vasc Biol 26 (2006) 534-540
10. Austin M.A. Epidemiology of hypertriglyceridemia and cardiovascular disease. Am J Cardiol 83 (1999) 13F-16F
11. Cavallero E., Brites F., Delfly B., et al. Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. Arterioscler Thromb Vasc Biol 15 (1995) 2130-2135
12. Brites F.D., Bonavita C.D., De Geitere C., et al. Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels. Atherosclerosis 152 (2000) 181-192
13. Dullaart R.P., and van Tol A. Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and type 2 diabetic patients to promote cellular cholesterol efflux. Atherosclerosis 157 (2001) 49-56
14. Fournier N., Atger V., Cogny A., et al. Analysis of the relationship between triglyceridemia and HDL-phospholipid concentrations: consequences on the efflux capacity of serum in the Fu5AH system. Atherosclerosis 157 (2001) 315-323
15. Fournier N., Francone O., Rothblat G., et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis 171 (2003) 287-293
16. de Vries R., Groen A.K., Perton F.G., et al. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification. Atherosclerosis (2007) [Epub ahead of print]
17. Mweva S., Paul J.L., Cambillau M., et al. Comparison of different cellular models measuring in vitro the whole human serum cholesterol efflux capacity. Eur J Clin Invest 36 (2006) 552-559
18. Castelli W.P. Lipids, risk factors and ischaemic heart disease. Atherosclerosis 124 Suppl. (1996) S1-S9
19. Gotto Jr. A.M. Rationale for treatment. Am J Med 91 (1991) 31S-36S
20. Atger V., Malon D., Bertiere M.C., N'Diaye F., and Girard-Globa A. Cholesterol distribution between high-density-lipoprotein subfractions HDL2 and HDL3 determined in serum by discontinuous gradient gel electrophoresis. Clin Chem 37 (1991) 1149-1152
21. Bortnick A.E., Rothblat G.H., Stoudt G., et al. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J Biol Chem 275 (2000) 28634-28640
22. Kritharides L., Jessup W., Mander E.L., and Dean R.T. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol 15 (1995) 276-289
23. Oram J.F., Lawn R.M., Garvin M.R., and Wade D.P. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J Biol Chem 275 (2000) 34508-34511
24. Peterson G.L. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83 (1977) 346-356
25. Thorngate F.E., Yancey P.G., Kellner-Weibel G., Rudel L.L., Rothblat G.H., and Williams D.L. Testing the role of apoA-I, HDL, and cholesterol efflux in the atheroprotective action of low-level apoE expression. J Lipid Res 44 (2003) 2331-2338
26. Yancey P.G., Asztalos B.F., Stettler N., et al. SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome. J Lipid Res 45 (2004) 1724-1732
27. de la Llera Moya M., Atger V., Paul J.L., et al. A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 14 (1994) 1056-1065
28. Fournier N., Atger V., Paul J.P., de la Llera Moya M., Rothblat G., and Moatti N. Fractional efflux and net change in cellular cholesterol content mediated by sera from mice expressing both human apolipoprotein AI and human lecithin:cholesterol acyltransferase genes. Atherosclerosis 147 (1999) 227-235
29. Duong M., Collins H.L., Jin W., Zanotti I., Favari E., and Rothblat G.H. Relative contributions of ABCA1 and SR-BI to cholesterol efflux to serum from fibroblasts and macrophages. Arterioscler Thromb Vasc Biol 26 (2006) 541-547
30. Wang X., Collins H.L., Ranalletta M., et al. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. J Clin Invest 117 (2007) 2216-2224
31. Tabas I. Cholesterol and phospholipid metabolism in macrophages. Biochim Biophys Acta 1529 (2000) 164-174
32. Favari E., Zimetti F., Bortnick A.E., et al. Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages. FEBS Lett 579 (2005) 6537-6542
33. Jessup W., Gelissen I.C., Gaus K., and Kritharides L. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 17 (2006) 247-257
34. Yu L., Cao G., Repa J., and Stangl H. Sterol regulation of scavenger receptor class B type I in macrophages. J Lipid Res 45 (2004) 889-899
35. Khovidhunkit W., Moser A.H., Shigenaga J.K., Grunfeld C., and Feingold K.R. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR. J Lipid Res 44 (2003) 1728-1736
36. Adorni M.P., Zimetti F., Billheimer J.T., et al. The roles of different pathways in the release of cholesterol from macrophages. J Lipid Res (2007) [Epub ahead of print]
37. Eisenberg S. Lipoprotein abnormalities in hypertriglyceridemia: significance in atherosclerosis. Am Heart J 113 (1987) 555-561
38. O'Brien K.D., Gordon D., Deeb S., Ferguson M., and Chait A. Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques. J Clin Invest 89 (1992) 1544-1550
39. Uehara Y., Miura S., von Eckardstein A., et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 191 (2007) 11-21
40. Palmer A.M., Murphy N., and Graham A. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells. Atherosclerosis 173 (2004) 27-38